eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in C rohn's disease

N Pedersen, M Elkjaer, D Duricova… - Alimentary …, 2012 - Wiley Online Library
Background Infliximab (IFX) maintenance therapy for C rohn's disease (CD) is administered
every 8 weeks, but inter‐patient variation in optimal treatment intervals may exist. Aim To …

eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease

N Pedersen, M Elkjaer, D Duricova, J Burisch… - core.ku.dk
BACKGROUND: Infliximab (IFX) maintenance therapy for Crohn's disease (CD) is
administered every 8 weeks, but inter-patient variation in optimal treatment intervals may …

eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease.

N Pedersen, M Elkjaer, D Duricova… - Alimentary …, 2012 - search.ebscohost.com
BACKGROUND: Infliximab (IFX) maintenance therapy for Crohn's disease (CD) is
administered every 8 weeks, but inter-patient variation in optimal treatment intervals may …

eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease

N Pedersen, M Elkjaer, D Duricova… - Alimentary …, 2012 - portal.findresearcher.sdu.dk
BACKGROUND: Infliximab (IFX) maintenance therapy for Crohn's disease (CD) is
administered every 8 weeks, but inter-patient variation in optimal treatment intervals may …

eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease

N Pedersen, M Elkjaer, D Duricova, J Burisch… - ikm.ku.dk
BACKGROUND: Infliximab (IFX) maintenance therapy for Crohn's disease (CD) is
administered every 8 weeks, but inter-patient variation in optimal treatment intervals may …

eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease

N Pedersen, M Elkjaer, D Duricova… - Alimentary …, 2012 - research.regionh.dk
BACKGROUND: Infliximab (IFX) maintenance therapy for Crohn's disease (CD) is
administered every 8 weeks, but inter-patient variation in optimal treatment intervals may …

[引用][C] eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease

N PEDERSEN, M ELKJAER… - Alimentary …, 2012 - pascal-francis.inist.fr
eHealth: individualisation of infliximab treatment and disease course via a self-managed
web-based solution in Crohn's disease CNRS Inist Pascal-Francis CNRS Pascal and …

eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in C rohn's disease

N Pedersen, M Elkjaer, D Duricova, J Burisch… - Alimentary …, 2012 - infona.pl
Background Infliximab (IFX) maintenance therapy for C rohn's disease (CD) is administered
every 8 weeks, but inter‐patient variation in optimal treatment intervals may exist. Aim To …

eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease

N Pedersen, M Elkjaer, D Duricova… - Alimentary …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Infliximab (IFX) maintenance therapy for Crohn's disease (CD) is administered
every 8 weeks, but inter-patient variation in optimal treatment intervals may exist. Aim To …

eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease.

N Pedersen, M Elkjaer, D Duricova… - Alimentary …, 2012 - europepmc.org
Background Infliximab (IFX) maintenance therapy for Crohn's disease (CD) is administered
every 8 weeks, but inter-patient variation in optimal treatment intervals may exist. Aim To …